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O~jeetives. The present study was designed to test the hypoth- 
esis that the direct thmmbin inhibitor hbxdin is mc~re efficient 
than beparln in reducing tkrmnhus Formation r&r coronary 
stenting. 
Background. Despite aggressive anticoagulatirr~. r&ztl;:e 
thrombosis of coronary stents is a major mmpticatton associated 
with these new devices. 
M&hods. In 19 minipigs indium-lll-tabeled thmmhwyies and 
ioditw1254abeled Ilbrinogen were injected 14 tn 19 It before 
commwy implantation of tantalum h&on-expnndable sttents. In 
group 1 (n = 6, seven rtents), a b&s of hsparin (100 U/kg body 
wefght) was given before stenting. Group 2 (II = 6. 11 stenls) 
nnived holh d&ran (500 ml) and hsparin ta 1MUikg bolus 
followed by P continuous infusion of SO U/kg per h). Ia group 3 
[n = 7,J3 statts), birudln (remmbinant desalphatoldrudin HV 1 
[CGP 393931 [I mgikg]) was given before stat Implantation, 
followed by cm lnfuslon of 1 m#kg per h. AU animals were 
txetreated with aspirin (250 mg intravenmtsly). 
rtonts in group 3. The aumber of pl*telets on 1 s&e& averz@ 
116.2 (range 22 to 5221 x lo” iagrmtp 1,643 ( e I1 tn 169) x 
lo6 in group 2 and 19.7 (range 9 to 38) X l@ in group 3 (p < LX@% 
vs. grouy 1 and KS. group 2). T&e increase in #&et 
awxiat?d with medial tear in all gmups, WPS Law& ia 
group. Simttarty, &&I depositiw was twvst en steats 
treated animals. 
reduction achieved with cmnblwd kelrzxin, dext%%n & 
(J Aa Cdl Canlid 1993,21:2&54) 
Percutaneous transluminal coronary angioplasty is increas- 
ingly applied as the primary revascttlarization procedure in 
patients with obstructive coronary artery disease (I,Z). 
However. two major problems limit its immediate and long- 
term success. Abnrpt coronary occlusion occurs in 2% to 
II% of patients (3.4) and restenosis of successfully dilated 
lesions is observed in 20% to 40% of patients (5.61. lntra- 
coronary stents have been suggested as a means to manage 
both acute occlusion, by pressing obstructive intimal tears to 
the vessel wall (7). and restenosis, by creating a large 
smooth-eontourcd lumen, preventing elastic recoil and pro- 
viding enough space for a reparative vessel response nor 
restthing in significant lumen obstruction (8.9). 
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However, stent thrombosis and restcnosis are observed 
both in eaperimental animals and in the clinical setting 
(IO-E). Thmmbus formation ntight cause or contribute to 
both adverse events as follows: II by Ieading to stem 
thrombosis and occlusion: 2) by stimulating smooth muscle 
cell proliferation by the action ofthrornbin or mitogens such 
as platelel-derived growth factor released from platelets 
(I 2.14), thereby causing significant lumen narrowing after 
several weeks. 
Hirudin. a specific thrombin inhibitor (IS), has been 
shown to reduce and even prevent platelet aggregation and 
fibrin deposition after balloon-induced arterial injury in a 
model of carotid angioplasty (16). The present study was 
designed to assess the effectiveness of hirudin in combina- 
tion wttn aspirin to prevent platelet aggregation and fibrin 
deposition on coronary stents in the immediate phase after 
imelantation. This auomach was cornoared with 1) an anti- . . 
coagulant regimen commonly used in~experimental studies 
(heparin as a bolus plus aspirin), and 2) the combination of 
dextran, aspirin and continuous bepariit infusion to prolong 
partial thromboplastin time, as is often used ia the clinical 
setting. 
Experimental preparation. Nineteen male or female 
minipigs of the Gottingen s&n were studied. The animals 
weighed between 21 and 41 kg and were approximately 
1 year old. After intramuscular sedation with nzaperone 
(10 m&g body weight), n c.Wrnl venous line was inserted 
throueh an ear vein. Blued war withdrawn from thiscatheter 
fur th;ambocyts labeling (see later). Platelets were rein- 
jetted together with ‘“‘I fibrinogen. Blood samples fur 
determination af free and cell-bound “‘In and ‘211 activity 
were obtained at timed intervals. 
After 14 to 18 h (mean 15.2 h), animals were placed under 
general anesthesia by rm intravenous injection of metomi- 
date (5 m&g), followed by pi&amide (Dipidolor) (I5 mg) 
and atropine (1 mg). Anesthesia was maintained by a cuu- 
tinuous intravenous infusio” of metomidate (8 to IO &kg). 
After orotrachenl int”bation, animals were ventilated by a 
2:l mixture of nitrous oxide and oxygen (Snlla 19 respirator). 
Blood gases were regularly monitored and ventilation wns 
adjusted as necessary to maintain blood gases in the physi- 
ologic range. 
The right cmnm~u carotid artery was expused and a 9F 
giant lumen coronary guide catheter was advanced into the 
ascending aorta. Tantalum ste:ds (‘IWO: :tents, Medtranic), 
premounted on Prime balloons with a nominal inflated 
diameter of 2.5, 3 or 3.5 mm, were placed into coronary 
artery segments of matched sizes under fluorwopic guid- 
ance. Stats were inflated twice at 6 to 8 atm for a total of 
30 s. Balloons were then d&ted and withdrawn. After an 
additional 12 h, patency of the stented and dilated caronary 
arteries was confirmed angiagrnphically. Midsternal thorn- 
cotomy was performed, the animals were killed by nn 
averdose of metomidate and the heart wns quickly excised, 
mounted in a retrograde aoriic peerfusion system and flushed 
with phosphate-buffered saline solution, followed by per- 
fusion fixation with caccdylic acid-buffered glutaraldehyde 
(!,XW ru!). The study was approved by the local ethics 
committee on animal research and conformed to the Amer- 
ican Heart Association guidelines. 
Anlieoaguiuriun. in six minipigs igrout~ 11, anticoagulant 
therapy consisted of a heparin bolus (100 U/kg) and aspirin 
(250 mg given intravenously 20 min before stat implanta. 
tian). Croup 2 (six minipigs) received dextran (molecular 
weight 40,CW) (500 ml intravenously); 200 ml wns given 
before stat placement and 300 ml was infused over 2 h r&r 
stat placer&t in addition to the heparin and aspirin bolus; 
heparin (50 Ulkg per h) was continuously infused intrnve 
nously. Group 3 (seven minipigs) received aspirin (250 mg 
intravenously) and, instead of heparin, hirudin (a b&s of 
1 mglkg followed by an infusion of I mgkg per h). The 
hirudin used is recombinant desulphatohirudin HV 1 (CGP 
39393), supplied and produced by Ciba-Geigy. Basel, Swit- 
zerland in collaboration with GEN Therapeutica, Bad 
Zwischennhn, Germany. Treatment during drug infusion 
was not administered in blinded fashion, but all subsequent 
tissue analyses, activity counting and laboratory testing 
were performed by investigntors (D. S., S. L.) who had no 
knowledge of the treatment given. 
Stentllg. In group I (six minipigs), seven stems were 
implanted in six left anterior descending coronary arteries 
and ane left circumflex artery. In group 2 (six minipigs), I1 
sterns were implanted in four left anterior descending and sir 
circumflex coronary arteries and one right curcmary artery. 
In group 3 (seven minipigs), 13 stents were implanted in 
seven left anterior descending and five circumflex coronary 
arteries and one right coronary nrtety. 
“‘In lahlin8 of platelets. Autologous platelets were la- 
beled according ton modified method of Laue et al. (17). The 
platelets were separated from 24 ml of blood, initially drawn 
directly into 6 ml of acid citrate dextrose. Finally, 3.7 MBq 
(100 Ci) of “‘In oxine (Amersham Buchler) was added. 
Lab&a efficiencv was 73 t 13% and olatelet recnverv was 
46 f 13%. 
Sterile water (I ml) was added to lyophilized human 
fibrinown (I.2 ma). which wns labeled with 4.07 MB” 
(110 &iX) of ‘=I (Amersham Buchler) 20 min before intrn: 
venous injection. 
Equal amwnts of activity were injected in each study: 
3 MBq “‘In-labeled platelets and 3 MBq ‘UI-labeled human 
fibrinogen. 
Blood samples were drawn at 15 mm and I, 2.4,6,18,20, 
24 and 28 h after injection. At the end of each experiment, 
activity of the samples wns counted in agnmma well counter 
using the double-window technique with spilldown correc- 
tion (30% from the 247&V “‘In window into the 35.keV 
lz51 window). A symmetric 5O.keV window centered around 
the 247 keV peak was used for “‘In, and a symmetric 
20-keV window centered amnttd 35 keV for ‘=I. Tvnical 
(background-corrected) count rates 24 h nfter inject& were 
between l.lW8 and 2.OW co”nts/min. Activitv in stented 
segments was deterudned as described for thi blond wn- 
pies. 
Hlstubglc analyh. After counting for “‘In and ‘=I ac- 
tivity, stents were further processed as previously described 
(18). In brief, alter dehydration in graded alcohol cottcentrn. 
tions, they were embedded in methacrylate. Five sections 
per stat of approximately ‘zW_lrrn thickness were prepared 
without prior removal of the stent wire and stained with 
toluidine blue. This procedure allowed microsconic analvsis 
of damage limited io the intima or extending beyond-the 
internal elastic membrane into the media. Segments were 
also analyzed for the presence and extent of thrombus on tl,e 
vessel wall or stat struts, or bath, and medial damage after 
toluidine blue staining. 
Lpbomtory testing. Blood samples for platelet count, 
hemog!nbin and hem~tncrit were i&en befdre stent place- 
ment and 12 h later. Activated nartial thromL&astin time 
(apIT), fibrinogen concentratia~, antithrmnbin~III (only in 
group 2) and plasma levels of hirudin (only in group 3) were 
measured before anticoagulant drugs were given and 1. 3.6 
and 12 h after steut implantation. 
c 
Figure I. One houraner stent implantation. aetwated partial ihmm- 
boplasti” time taPTTI was significantty prolonged by a factor of 
~1.8 compared with contml val”e~ 1” all groups. I” &ro”p I IA. 
hepari” bolus + aspirin). all subsequent measurements rhowd 
aPTT wl”es not diRerent fro”, control values. while 1” buth group ? 
(*. c”“ti”u”“s bepaii” + dertnn + aspirin) and group 3 t 
+ aspirinl. aPIT remained prolonged throughout the erpcnments 
L = lime. *p C 0.05. 
Slalisiics. For comparison of the laboratory variables in 
the three groups, the Kruskal-Wallis test was used. Values at 
different rimes within a group were compared by Wdcoxon 
test. A p value ~0.05 was considered to indicate statistical 
significance. 
Platelet and fibrin deposition oo stats were analyzed 
with “se of a multivariate mixed linear model (19). This 
model was calculated separately for both target variables: 
olatelet and fibrin deoosition. Covariables were 1) anticone- 
&ion; 2) Ibe target vessel stented (Ien anterior descending. 
left circumflex or right coronary artery): 3) stem size: and 
4) presence of medial tear. The ~tructttre of the dara was as 
follows: 31 observations in 19 minipigs, I to 3 obrervationr 
per minipig. By osinp the multiple test procedure of SchetE 
(201, data were analyzed for equality at the 5% level among 
all three groups. Anticoagulation was considered as a fixed 
factor. The square of the stent size was modeled as a fixed 
factor to account for differences in stem surface. All other 
covariables were considered to be random. These results are 
presented as a mean value and range of values. The multiple 
5% level was considered to indicate statistical significance. 
All stems were successfully implanted and were patent 
after I? h. 
Laboratory variables. Activated partial thromboplastin 
time (aPTTl in ~ro”s I minioias was orolowed onlv at I h .- I I I 
after stat lmplam~tion and then returned to normal. In 
groups 2 and 3. the aF‘l’T was prolonged to >2 times the 
control values after I hand remained prolonged throughout 
the experimental course (Fig. il. 
Antlthrombin III. measured on!y in group 2. was 130.9 ? 
4.S% at bareline and showed a slight but insignificant de- 
crease to 110.3 ? 4.3% after I2 h. Plasma fibrinogen, platelet 
count and hematocrit were not significantly different among 
groups and showed no significant changes over time within 
the groupr (Table Il. 
In group I minipigs heparin levels increased from O.il ? 
0.08 to 0.3T i 0.08 after I b but subsequent levels did not 
differ from values before administration of the heparin bolus 
(Table 21. Heparin plasma levels in group 2 increased from 
0. IO )- 0 IX? hefore heparin administration to 0.46 ? 0.48 at 
I h and averaged 2.37 C 0.22 after 12 h (p < 0.01 vs. control 
VtilUCl. 
Hirudin levels in plasma of group 3 m&pigs iacreased to 
5.51 ? I .38 &ml after 1 h and averaged 9.09 -r 4.06 &ml 
after I? h (Table 2). 
Hislolo~ic analysis. Thrombus was present on all sections 
in “II stems and was most extensive ip. those stents that 
showed evidence of suhintimal damage (medial tear or frag- 
mentation of the media). Subintimal damage was present in 
three control strnts and in six stems each in groups 2 and 3. 
Plaalrt &position. In group I minipigs (heparin and 
aspirin). there was a mean of 116.2 (range 22.3 to 522) x 
IO6 plateletnhtent. In group 2. aspirin, dextran and contin- 
ued heparm administration resulted in a reduction to 64.3 
tmnge It to lh!Jl x IO6 plateletslstcn!. In &w~~p 3, hirodin 
and aspirin treatment resulted is 2 reduction of platelet 
deposition to 19.7 (range 9.2 to 38) X IO6 olateletslstent. This 
difference w”= largely due to diiTeren&s in numbers of 
platelets dep.,r,ted on stems with a” intimal tear. Platelet 
deposition on ‘!we steots in the hirudin-treated group was 
only slightly g. ::.ter than that on stems without a medial 
tear. In co”tra~t. platelet deposition in groups 1 and 2 
increased substantially in tuose stats with a medial tear 
over values obtained in stats without an intimal tear (Fig. 
2). 
Analysis using the multivariate mixed Linear model 
showed that steot size and the vessel stated had no detect- 
able effect an either platelet or fibrin deposition. 
Fibrin deposirion. On seven stents in group I minipigs. 
an average of 407.4 (range 64 to 1,015) t,g of fibrinlstent was 
deposited. Minipigs in group 2. treated with continuous 
hepmin infusion, aspirin and dextran, showed less fibrin 
deposition, 321.3 (range 50 to 1,030) w&tent. Fibrin depo- 
sition was least in minipigs treated with &din (group 3) &d 
averaged 147.8 (range 29 to 367) &tent (p 4 0.05 at the 
multiple level]. 
Similar to olatekt deoosition. fibrin deoosition on stems 
with a mediai tear was’signitic~otly greater than in stents 
without a medial tear in all groups (Fig. 3). However. on 
those stents in segments with medial damage, there were 
large increases in fibrin deposition in both groups I and 2, 
whereas in the hirudin-treated minipigs in group 3, fibrin 
deposition was only moderately greater than that on stems 
without a medial tear. 
Discussion 
The present study shows that recombinant himdin, in 
combination with aspirin, significantly reduces platelet and 
Figure 2. Platelet deposition an stems with a medial tear(opn bars) 
is significantly higher than that on stents witnout a medial tear 
(hatched bars) in all gmups. ‘Values in all three groups are pairwise 
significantly different at the multiple 5% level. p < 0.05 indicates the 
significant influence of medial tear on platelet deposition at the 
multiple 5% level. The wttcst lines in each bar represent the 
range of mearured valuer. “eparin - Bolus = group I; Hepatin - 
Infusion = group 2; Himdin - Infusion = group 3. 
fibrin deposition on coronary tantalum stents compared with 
the deposition observed after either administration of a 
heparin bolos or combined treatment with dextran, aspirin 
and conlinuous infusion of heparin. 
Tkrombus formation on stats. Thrombotic occlusion is 
an acknowledged risk of coronary stat implantation in 
humans and is observed in up to 2S% of patients. Those 
patients who undergo steniing for an occlosivc dissectioo 
after coronary angioplasty are particularly at risk of devel- 
oping this complication (il,lZ]. 
In contrast. thrombotic occlusion of stems in experimen- 
tal animals is rarely observed even though, by comparison 
with clinical practice, the anticoagulant regimen is much less 
aggressive. otien including only a heparin bolus at the time 
of implantation and, occasionally, daily aspirin (10.2l.223. 
However, nonocclusive thrombus formation on inlravascu- 
lar stats has been shown in animals killed after hours to 
several davs after stent imolantation (22). Such thmmbus 
was later replaced by proliferating n&iotima, suggesting a 
role for platelet-rich thmmbus in the development of resten- 
osis within stents as well. Thus, prevention of lhrombus 
formation after stentiog could possibly lead to better imme- 
diate and long-term results. 
Whereas Heras et al. (23) and Lam et al. (24) showed a 
reduction in platelet and thmmbus deposition after balloon 
Figore 3. Fibrin deposition on stents with a medial ear (apo tars) 
is significantly higher than that on stats without a medial tear 
(hatched bus) in the three treatment groups. *Indicates that pair- 
wise comparison of the three treatment groups showed lba~ values 
in the hirudin-treated group were significantly lower than values 
in the other groups at the multiple 5% level. p < 0.05 indicates 
the significant influence of medial tear on fibrin deposition at the 
multiple 5% level. The verttcnt liner in each bar remesent the range 
of measured values. Gmups as in Figure 2. 
angioplasty in pig carotid arteries usinz hepxin at doses 
resulting in sy%mic anticoagulation, &&ski et al. (25) 
found a heparin-resistant thrombus formation on stcntc 
placed in exteriorized vascular grafts in baboons. 
Role of hiidin. The latter observation can be explained 
by the inability of heparin to inhibit fibrin-bound thromhin 
(25). Consequently, administration of hirudin, a direct, 
antithrombin-Ill-independent, inhibitor of thrombin pre- 
vented thrombus formation after deep arterial injury signif- 
icantly better than did hepmin (16). Heras et al. (16) estab 
lished the dose dependency of the hirudin effect, such that 
prolon@ion of the activated partial thromboplastin time 
must be achieved for the most effective prevention of 
thrombus formation. A balus dose of I mglkg followed by an 
infusion of I mglkg per h was found optimal. 
This optimal hirudin dose of I mgfkgper h was used in our 
study and by the time of stent implantation resulted in a 
prol&ed uPIT that was maintained throughout the 12-h 
experimental period. Similar to the results of Hems et al. 
(16). hirudin caused u significant reduction of platelet and 
fibrin deposition on coronary stents. This effect was partic- 
ularly evident in those stated segments that showed a 
medial tear on histologic examination. that is. deep urtenal 
iniurv. This findine sutwmts the studv of Herus et al. (16). 
who~also found hi&din io be most e&ix in areas of d&p 
arterial injury. 
The reduced thrombus fortnation on stents in those 
minipigs that received a continuous hepmin infusion plus 
dextnm was also significantly lower than that in minipigs 
treated by a hepwin bolus alone. This observation is in 
accordance with a study (23) reporting a decreasing umount 
of thromhus formation with increasing hepwin dosage in a 
balloon angioplasty model. However, the reduction was 
modest and did not reach the extent observed with hirudin 
treatment. 
, 
The absolute number of ulate!ets deoosited DPT cm- of . . 
stat surface in our study is higher than that reported by 
Hems et al. (161. who found 7 t I x K&m2 of deeolv 
injured arterial surface. In our study, a mean of 21.1. x 
lo6 plateletslstents with medial tear were found in the 
hiidii-treated group and a mean stent surface of 1.4 cm2 
resulted in approximately 17 x Iti platelets/cm’ stem JUT- 
face. This difterence might be explained by the additional 
thmmbogenic stimulus of stents. requiring a more intense 
antithmmbatic therapy. However. Steele et al. (26) reported 
54 x lO%m* platelets deposited after carotid angioplasty in 
pigs treated with heparin, and this is in the range of platelet 
deposition for the control group without anticoagulant her- 
apy in the study of Heras et al. (16). Thus, the absolute 
number of platelets deposited might not be comparable 
among individual studies. Further studies ure necessary to 
clarify whether an increased dose of hirudin can further 
reduce platelet deposition without increasing the bleeding 
risk. 
Other ihmmbin inhibitors. In a study on stats placed 
into vascular grafts in baboons, Kmpski et al. (2;) studied 
the comparative etTects of the synthetic antithrombin Phe- 
Pro-Arg-chlommethyl ketone and of heparin on thrombus 
formatmn. Whereas systemic heparin showed no sign&cant 
effect, the antithrombin significantly decreased the number 
of platelets deposited. Iang et al. (27) infused the synthetic 
thrombin inhibitor argutroban intravenously in rabbits, in 
which an everted (insideatt) arterial segment had heen 
inserted into a femoral awry. In contrast to heparin, arga- 
troban prevented the thromhotic occlusion of those seg- 
ments in all CPSOE. 
lm~lications for late stent steno& Steele et al. (26) pre- 
sented experimental evidence for the hypothesis that the 
degree of restenosis after carotid ballcon angioplasty de- 
pends, at least in part. on the amouni of :oc.G !!?rombus 
formation duringorimmediately after angioplasty. Rousseau 
et al. (22) and Schatz et al. (28) reported serial histologic data 
after peripheral and coronary stat implantaiion, suggesting 
organization of acutely formed thmmbus by neointimal 
proliferation. In addition to the mere organization of throm- 
bus as the basis for late stenosis, experimental evidence 
suggests that stimulation of smooth muscle cell migration 
and proliferation by platelet-released mitogens (such as 
platelet-derived gmwh factor [291) to be a major contributor 
to late stenosis after angioplusty. On the basis of these data 
it can be speculated that reduced early thrombus formation 
(by himdin) could result in less long-term neointimal prolii- 
emtion because I) less thrombus would be available to be 
organized, 2) there would be less release ofmitogenic stimuli 
for smooth muscle cells. 
Conclusiuns. Available experimental evidence suggests 
that thrombin has a critical t& in the formation of arterial. 
ok&let-rich thrombus. Treatment with heumin fails to ore- 
ient this effect. The present study showsihat recombi& 
hirudin significantly decreases platelet and fibrin deposition 
on coronary stents in minipigs. This eiiect is particularly 
evident in the presence of deep arterial injury, a condition 
encountered in the clinical situation of occlusive dissection 
after coronary angioplasty. Thus, hintdin has a potential mle 
in the treatment of patients who receive a stent as .L rescue 
device for acute &nary occlusion. Because thmmbus 
formation, by the omliferative effect of thmmbin and 
pi&i:-de&d gro&h factor on vascular smooth muscle 
cells, may contribute to late restenosis after angiaplasty and 
stem implantation, thrombin inhibition by hiidin could also 
improve the late outcome. 
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